Results 131 to 140 of about 48,181 (245)

A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice Immunological evidence [PDF]

open access: bronze, 1991
F. Pons   +9 more
openalex   +1 more source

Prenatal genetic counselors' attitudes, beliefs, and practices with discussing postnatal Duchenne muscular dystrophy treatment options

open access: yesJournal of Genetic Counseling, Volume 34, Issue 6, December 2025.
Abstract Duchenne muscular dystrophy (DMD) is an X‐linked genetic condition characterized by progressive muscle degeneration. Recently, several genotype‐specific treatment options for DMD have become available. Prenatal genetic counselors may encounter at‐risk patients for DMD, through a variety of indications.
Shawna L. Jurlina   +3 more
wiley   +1 more source

Overuse‐Induced Muscle Disorder: Establishing a Rat Model to Unravel the Role of Fibro‐Adipogenic Progenitor Cells in Intramuscular Fibrosis

open access: yesJournal of Orthopaedic Research, Volume 43, Issue 12, Page 2102-2113, December 2025.
ABSTRACT Overuse‐induced muscle disorders (OIMD) frequently occur in athletes due to excessive and improper use under high physical demand, often leading to muscle pain and weakness. Limited studies have shown intramuscular fibrosis in OIMD, with fibro‐adipogenic progenitors (FAPs), also known as mesenchymal stromal cells (MSCs), playing a crucial role
Hiroyori Fusagawa   +17 more
wiley   +1 more source

Dietary Phosphorus Overload Aggravates the Phenotype of the Dystrophin-Deficient mdx Mouse [PDF]

open access: bronze, 2014
E. Wada   +10 more
openalex   +1 more source

Detection of a specific isoform of alpha-actinin with antisera directed against dystrophin. [PDF]

open access: bronze, 1989
Eric P. Hoffman   +3 more
openalex   +1 more source

A 12‐Week Strength Training Improves Mitochondrial Respiration, H2O2 Emission and Skeletal Muscle Integrity in Women With Myotonic Dystrophy Type 1

open access: yesActa Physiologica, Volume 241, Issue 12, December 2025.
ABSTRACT Background Myotonic dystrophy type 1 (DM1) is caused by expanded CTG repeats in the DMPK gene, causing the accumulation of toxic RNA that sequesters RNA‐binding proteins. Clinically, DM1 is characterized by progressive muscle weakness and atrophy, resulting in reduced physical capacity and quality of life.
Vincent Marcangeli   +13 more
wiley   +1 more source

Comprehensive Profiling of Annexins in Neuromuscular Disorders Reveals a Unique Signature in Dysferlinopathy

open access: yesEuropean Journal of Neurology, Volume 32, Issue 12, December 2025.
Muscle biopsies from patients across eight neuromuscular disorders and healthy controls were analyzed using immunofluorescence (IF) and immunoblot (WB) to evaluate the expression and localization of seven annexin proteins (A1, A2, A4, A5, A6, A7, A11).
Qi‐Fang He   +11 more
wiley   +1 more source

Exploring the respiratory efficacy of combined chronic glucocorticoid and antioxidant interventions in the mdx mouse: The PREDNAC trial

open access: yesExperimental Physiology, Volume 110, Issue 12, Page 2019-2035, December 1, 2025.
Abstract Duchenne muscular dystrophy (DMD) is characterized by respiratory muscle injury and weakness, ultimately leading to respiratory failure. Impaired respiratory muscle performance, fibrosis and inflammation in early disease are evident in the dystrophin‐deficient mdx mouse model of DMD.
Michael N. Maxwell   +3 more
wiley   +1 more source

Temporal Bayesian classifiers for modelling muscular dystrophy expression data [PDF]

open access: yes, 2006
The analysis of microarray data from time-series experiments requires specialised algorithms, which take the temporal ordering of the data into account. In this paper we explore a new architecture of Bayesian classifier that can be used to understand how
Hoen, PAC't   +3 more
core  

Home - About - Disclaimer - Privacy